53 proof-checking-postdoc-computer-science-logic Fellowship positions at University of Bergen
Sort by
Refine Your Search
-
, model validation, and optimizing AI methodologies for clinical implementation. About the LEAD AI fellowship programme LEAD AI is the University of Bergen's career and mobility fellowship program for
-
in an approved educational programme for a PhD degree within a period of 3 years. The deadline for applying for admission to the PhD programme at The Faculty of Science and Technology is 2 months after
-
systems. Qualifications and personal qualities Applicants must hold a master's degree or equivalent education in weather and climate sciences, physical oceanography and meteorology, applied mathematics
-
or computational chemistry with a specialization in cheminformatics, structure-based drug design or a related field. PhD-students may apply if defence of the PhD-thesis is completed by 1.11.2025. It is
-
to the PhD programme at The Faculty of Science and Technology is 2 months after you start your position or after the start of the research project that will lead to the PhD degree. It is a condition that you
-
programme for a PhD degree within a period of 3 years. The deadline for applying for admission to the PhD programme at The Faculty of Science and Technology is 2 months after you start your position or after
-
(e.g. teaching at the Institute). The position is associated with the research group in energy at the Geophysical Institute, the Bergen Offshore Wind Center and the energy informatics lab
-
degree in digital culture, digital humanities, computational media, literary studies, media studies, creative writing, or a related field, including computer science. It is a condition of employment that
-
, computational media, literary studies, media studies, creative writing, or a related field, including computer science. It is a condition of employment that the master's degree has been awarded by the application
-
by the EU programme Horizon Europe. The main aim of the project is to unveil the role of the Epstein-Barr virus (EBV) in the onset and progression of the Multiple Sclerosis (MS) disease. The position